Successful Completion of Phase 1 Clinical Trial, Close of Initial Equity Round of Funding, and Addition of Dr. Stanley Marks and John Friedman to Board of Directors Positions CytoAgents for Larger Series A and Phase II Trials. Read more >>
Myomo, Inc., a wearable medical robotics company, announced today that Micah Mitchell is joining the company as chief commercial…
read morePlatelet BioGenesis, Inc. (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, today announced that…
read moreBrandVerge, a premium advertising marketplace that connects media companies and advertisers on-demand, today announced it has expanded to include…
read moreFor the past nine years, Charlotte Baker has had one dream. Her vision is restored and her life returns…
read moreThe White House has nominated the president and chief executive of suborbital spaceplane and engine developer XCOR Aerospace to…
read moreSilo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psychedelics as a therapeutic,…
read moreBoston Harbor Angels has invested in two neuroscience startups targeting stroke, TBI and Parkinson’s Disease, leading a $1.3M angel…
read moreCanned wine isn’t just found on grocery store shelves and at outdoor festivals these days…An increasing awareness of sustainability…
read moreRegroup Mass Notification, the award-winning provider of emergency and day-to-day mass communication technology, today announced its official recognition as…
read moreKnowing the enormous utility costs associated with running a science facility, Georgetown’s Energy and Utilities department invited Aircuity to…
read more